Based on these considerations and on knowledge about the requirements of effective apoptosis induction by TRAIL ligands, we investigated whether it is possible to generate a MSC line stably producing a highly bioactive, tumor-targeted single-chain TRAIL fusion protein under retention of its full MSC properties. Here, TNFSF10 is linked to neoplasm.